For metabolism disorder.
Brand Name(s): Elelyso
Generic Name: Taliglucerase Alfa
Instructions
This medicine is given as an IV injection into a vein.
This medicine should be given over 1 to 2 hours.
This medicine should be given by a trained health care provider.
It is important that you keep taking each dose of this medicine on time even if you are feeling well.
If you miss a dose, contact your doctor for instructions.
Drug interactions can change how medicines work or increase risk for side effects. Tell your health care providers about all medicines taken. Include prescription and over-the-counter medicines, vitamins, and herbal medicines. Speak with your doctor or pharmacist before starting or stopping any medicine.
Tell your doctor if symptoms do not get better or if they get worse.
Keep all appointments for medical exams and tests while on this medicine.
Cautions
During pregnancy, this medicine should be used only when clearly needed. Talk to your doctor about the risks and benefits.
Tell your doctor and pharmacist if you ever had an allergic reaction to a medicine.
This medicine has been associated with a rare but serious skin rash. If you notice any red, peeling or blistered skin, contact your doctor immediately.
Some patients taking this medicine have experienced serious side effects. Please speak with your doctor to understand the risks and benefits associated with this medicine.
It is unknown if this medicine passes into breast milk. Ask your doctor before breastfeeding.
Contact your doctor immediately if you experience any swelling of your hands, face, lips, eyes, throat or tongue.
Side Effects
The following is a list of some common side effects from this medicine. Please speak with your doctor about what you should do if you experience these or other side effects.
- flu-like symptoms
- headaches
- pain, redness, swelling near injection
- pain in the joints
- runny nose
- sore throat
Call your doctor or get medical help right away if you notice any of these more serious side effects:
- chest pain
- coughing
- swelling of the face, mouth, tongue, or throat
- fainting
- feeling of heat or flushing
- low blood pressure
- nausea and vomiting
- red, burning, or itchy skin
- shortness of breath
A few people may have an allergic reaction to this medicine. Symptoms can include difficulty breathing, skin rash, itching, swelling, or severe dizziness. If you notice any of these symptoms, seek medical help quickly.
Please speak with your doctor, nurse, or pharmacist if you have any questions about this medicine.
IMPORTANT NOTE: This document tells you briefly how to take your medicine, but it does not tell you all there is to know about it. Your doctor or pharmacist may give you other documents about your medicine. Please talk to them if you have any questions. Always follow their advice.
There is a more complete description of this medicine available in English. Scan this code on your smartphone or tablet or use the web address below. You can also ask your pharmacist for a printout. If you have any questions, please ask your pharmacist.
The display and use of this drug information is subject to Terms of Use.
More information about TALIGLUCERASE ALFA - INJECTION
Copyright(c) 2024 First Databank, Inc.
Selected from data included with permission and copyright by First DataBank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
Conditions of Use: The information in this database is intended to supplement, not substitute for the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment. The display and use of this drug information is subject to express Terms of Use.
